CBT
CBT
NYSE · Chemicals

Cabot Corp

$87.49
-3.21 (-3.54%)
Financial Highlights (FY 2026)
Revenue
3.54B
Net Income
315.25M
Gross Margin
25.3%
Profit Margin
8.9%
Rev Growth
-4.9%
D/E Ratio
0.73
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 25.3% 25.3% 49.7% 49.7%
Operating Margin 16.7% 15.1% 9.8% 10.6%
Profit Margin 8.9% 8.5% 7.8% 8.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.54B 3.72B 185.80M 154.67M
Gross Profit 895.40M 941.84M 92.35M 76.88M
Operating Income 591.63M 560.08M 18.27M 16.44M
Net Income 315.25M 298.44M 14.53M 13.23M
Gross Margin 25.3% 25.3% 49.7% 49.7%
Operating Margin 16.7% 15.1% 9.8% 10.6%
Profit Margin 8.9% 8.5% 7.8% 8.6%
Rev Growth -4.9% -4.9% +7.5% +12.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 999.02M 999.02M 777.42M 779.25M
Total Equity 1.37B 1.37B 2.58B 2.20B
D/E Ratio 0.73 0.73 0.30 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 738.13M 737.59M 24.94M 19.49M
Free Cash Flow 7.01M 6.93M